A Six-Gene Signature Predicts Survival of Patients with Localized Pancreatic Ductal Adenocarcinoma
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Six-Gene Signature Predicts Survival of Patients with Localized Pancreatic Ductal Adenocarcinoma
Authors
Keywords
-
Journal
PLOS MEDICINE
Volume 7, Issue 7, Pages e1000307
Publisher
Public Library of Science (PLoS)
Online
2010-07-14
DOI
10.1371/journal.pmed.1000307
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Microarray Technologies for Gene Transcript Analysis in Pancreatic Cancer
- (2014) C. P. Kolbert et al. TECHNOLOGY IN CANCER RESEARCH & TREATMENT
- New Markers of Pancreatic Cancer Identified Through Differential Gene Expression Analyses: Claudin 18 and Annexin A8
- (2009) Zarir E. Karanjawala et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Long-Term Survival After Pancreatoduodenectomy for Pancreatic Adenocarcinoma
- (2009) Thomas Schnelldorfer et al. ANNALS OF SURGERY
- Surgeon Volume Impacts Hospital Mortality for Pancreatic Resection
- (2009) Robert W. Eppsteiner et al. ANNALS OF SURGERY
- A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer
- (2009) H Ueno et al. BRITISH JOURNAL OF CANCER
- Activation of Host Wound Responses in Breast Cancer Microenvironment
- (2009) M. A. Troester et al. CLINICAL CANCER RESEARCH
- Prognostic signature for pancreatic cancer: are we close?
- (2009) Jen Jen Yeh Future Oncology
- Phase III Trial of Bevacizumab in Combination With Gemcitabine and Erlotinib in Patients With Metastatic Pancreatic Cancer
- (2009) Eric Van Cutsem et al. JOURNAL OF CLINICAL ONCOLOGY
- KRAS/BRAF mutation status and ERK1/2 activation as biomarkers for MEK1/2 inhibitor therapy in colorectal cancer
- (2009) J. J. Yeh et al. MOLECULAR CANCER THERAPEUTICS
- Readmissions Following Pancreaticoduodenectomy for Pancreas Cancer: A Population-Based Appraisal
- (2008) Irina Yermilov et al. ANNALS OF SURGICAL ONCOLOGY
- The role of KLF6 and its splice variants in cancer therapy
- (2008) Analisa DiFeo et al. DRUG RESISTANCE UPDATES
- Increased alternative splicing of the KLF6 tumour suppressor gene correlates with prognosis and tumour grade in patients with pancreatic cancer
- (2008) Mark Hartel et al. EUROPEAN JOURNAL OF CANCER
- Preoperative Gemcitabine and Cisplatin Followed by Gemcitabine-Based Chemoradiation for Resectable Adenocarcinoma of the Pancreatic Head
- (2008) Gauri R. Varadhachary et al. JOURNAL OF CLINICAL ONCOLOGY
- Preoperative Gemcitabine-Based Chemoradiation for Patients With Resectable Adenocarcinoma of the Pancreatic Head
- (2008) Douglas B. Evans et al. JOURNAL OF CLINICAL ONCOLOGY
- Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
- (2008) S. Jones et al. SCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started